Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 326-350 of 861 matching filings.

Per page
25
Current page
14
8-K File 000-51531

FORM 8-K

Filing date
10 Jul 2019
Reporting date
10 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K NOTICE OF FAILURE TO SATISFY A CONTINUED LISTING RULE

Filing date
09 Jul 2019
Reporting date
09 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2019
Reporting date
28 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K 2019 ANNUAL MEETING VOTE SUBMISSION

Filing date
06 Jun 2019
Reporting date
06 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-231342

2019 S-8

Filing date
09 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-51531

Q1 2019 10-Q

Filing date
08 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
8-K File 000-51531

Q1 2019 EARNINGS 8-K

Filing date
08 May 2019
Reporting date
08 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

8-K DEBT REFINANCING

Filing date
29 Apr 2019
Reporting date
26 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-51531

2019 DEFA14A

Filing date
12 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-51531

2019 DEF 14A

Filing date
12 Apr 2019
Reporting date
06 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Apr 2019
Reporting date
29 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Apr 2019
Reporting date
29 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
25 Mar 2019
Reporting date
14 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-51531

CT ORDER filing

Filing date
18 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-51531

CT ORDER filing

Filing date
18 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

Q4'18 EARNINGS 8-K

Filing date
07 Mar 2019
Reporting date
07 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Mar 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

AMENDMENT NO. 5 TO THE SCHEDULE 13G

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .